Regorafenib plus FOLFIRI with irinotecan dose escalated according to uridine diphosphate glucuronosyltransferase 1A1genotyping in previous treated metastatic colorectal cancer patients:study protocol for a randomized controlled trial

Peer Review reports

Original Submission
31 May 2019	Submitted	Original manuscript
4 Oct 2019	Author responded	Author comments - Cheng-Jen Ma
Resubmission - Version 2
4 Oct 2019	Submitted	Manuscript version 2
7 Nov 2019	Reviewed	Reviewer Report - Benjamin Kasenda
11 Nov 2019	Author responded	Author comments - Cheng-Jen Ma
Resubmission - Version 3
11 Nov 2019	Submitted	Manuscript version 3
Publishing
18 Nov 2019	Editorially accepted
19 Dec 2019	Article published	10.1186/s13063-019-3917-z

Back to article page